Digital Therapeutics Sarcopenia Market Forecast 2026–2035: How to Leverage Market Growth

Uncover key drivers, emerging technologies, and competitive movements shaping the digital therapeutics sarcopenia market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Digital Therapeutics Sarcopenia Market expected to reach by 2030?

Significant expansion has been observed in the digital therapeutics sarcopenia market size in recent years. This market is forecasted to increase from $1.54 billion in 2025 to $1.78 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.1%. The historical growth can be attributed to several factors, including the increasing prevalence of an aging population, heightened awareness of sarcopenia-related health risks, the expansion of telehealth adoption, the growing acceptance of software-based medical therapies, and early clinical validation of digital interventions.

The digital therapeutics sarcopenia market size is projected for substantial expansion in the coming years. It is anticipated to grow to $3.21 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 15.9%. This expected growth can be attributed to several factors, including the increasing demand for managing chronic conditions at home, the rising incorporation of AI-driven therapeutic personalization, the broader availability of reimbursement support for digital therapeutics, the growing acceptance of remote patient monitoring, and a heightened focus on solutions for preventive muscle health. Major trends foreseen during this period involve the increasing adoption of personalized digital therapy programs, the rising use of muscle monitoring integrated with wearable technology, the growing deployment of remote physiotherapy platforms, the expansion of data-driven sarcopenia management solutions, and an enhanced emphasis on patient engagement and adherence.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27278&type=smp

What Drivers Are Driving Adoption Within The Digital Therapeutics Sarcopenia Market?

The expansion of the digital therapeutics sarcopenia market is anticipated to be fueled by the increasing occurrence of comorbidities. Comorbidities are defined as the simultaneous presence of two or more health conditions within a single individual. The rise in these conditions is linked to an aging global population, as older individuals are more prone to developing multiple chronic ailments due to declining bodily functions and prolonged exposure to various health risks. Digital therapeutics designed for sarcopenia offer advantages in preventing comorbidities, particularly obesity, by promoting consistent physical activity and muscle strengthening, which, in turn, enhances metabolism and diminishes fat accumulation. For instance, in March 2024, figures from the World Obesity Federation, a UK-based membership organization, projected that close to 79% of adults impacted by overweight and obesity are expected to be living in low- and middle-income nations by the year 2035, with the total number of adults with obesity forecasted to reach 1.53 billion. Consequently, the growing prevalence of comorbidities is a key factor stimulating the growth of the digital therapeutics sarcopenia market.

How Is The Digital Therapeutics Sarcopenia Market Organized Into Various Segments?

The digital therapeutics sarcopenia market covered in this report is segmented –

1) By Product: Software, Devices, Services

2) By Distribution Channel: Online Platforms, Direct-To-Consumer Digital Channels, Other Distribution Channels

3) By Application: Muscle Strengthening, Physical Activity Monitoring, Nutrition Management, Other Applications

4) By End User: Hospitals And Clinics, Homecare Settings, Rehabilitation Centers, Other End Users

Subsegments:

1) By Software: Mobile Applications, Web-Based Platforms, AI-Powered Monitoring Tools, Exercise And Rehabilitation Programs, Nutritional Guidance Software

2) By Devices: Wearable Fitness Trackers, Smart Scales, Connected Resistance Bands, Electromyography (EMG) Devices, Muscle Strength Assessment Tools

3) By Services: Remote Patient Monitoring Services, Virtual Physiotherapy Sessions, Teleconsultation Services, Personalized Coaching Services, Data Analytics And Reporting Services

What Trends Are Expected To Impact The Competitive Landscape Of The Digital Therapeutics Sarcopenia Market?

Major companies within the digital therapeutics sarcopenia market are concentrating their efforts on creating advanced solutions, particularly drug discovery platforms, aiming to develop more targeted treatments, improve the efficacy of therapies, and accelerate the provision of personalized care for age-associated muscle degeneration. Such platforms facilitate the more rapid and efficient identification and creation of novel medications through the application of sophisticated tools and methodologies. For instance, in April 2025, ProFuse Technology, an Israel-based biotechnology company, introduced a new drug discovery platform specifically focused on preventing muscle loss resulting from GLP-1 weight-loss drugs, aging (sarcopenia), and cancer cachexia. By utilizing highly developed, laboratory-cultivated muscle tissues designed to replicate natural muscle, the firm can precisely test and screen potential drug compounds with greater speed and efficiency. This cutting-edge platform diminishes the need for animal experimentation and concurrently reduces expenditure on research. Given the increasing demand for therapies aimed at preserving muscle, ProFuse is expanding its operations from cultivated meat into the biopharmaceutical sector, thereby presenting an innovative strategy to tackle the escalating challenges in muscle health.

Who Are The Prominent Global Companies Shaping The Digital Therapeutics Sarcopenia Market Landscape?

Major companies operating in the digital therapeutics sarcopenia market are Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Lark Technologies Inc., Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, Cometa Srl., Koneksa Health Inc., Physitrack PLC, Kaia Health Inc., XRHealth USA Inc., MedRhythms Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/digital-therapeutics-sarcopenia-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Digital Therapeutics Sarcopenia Market?

North America was the largest region in the digital therapeutics sarcopenia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics sarcopenia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Digital Therapeutics Sarcopenia Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27278&type=smp

Browse Through More Reports Similar to the Global Digital Therapeutics Sarcopenia Market 2026, By The Business Research Company

Battery Separators Market Report 2026

https://www.thebusinessresearchcompany.com/report/battery-separators-global-market-report

Cutter Stapler Market Report 2026

https://www.thebusinessresearchcompany.com/report/cutter-stapler-global-market-report

Battery Manufacturing Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/battery-manufacturing-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795